PNGAF OTC
The Precision Peptide Company Inc
1W: -11.8%
1M: -4.9%
3M: -23.7%
YTD: +37.1%
1Y: +15.8%
3Y: +182.4%
$0.28
-0.02 (-7.50%)
Weekly Expected Move ±8.6%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$50K
+307.4% ▲
4Y CAGR: -7.7%
Gross Profit
-$69K
-1101.6% ▼
Operating Income
-$2M
-144.6% ▼
Net Income
-$5M
-339.0% ▼
EPS (Diluted)
$-0.21
-40.0% ▼
EBITDA
-$2M
-135.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $68K | $698K | $286K | $12K | $50K |
| YoY Growth | +0.0% | +919.4% | -59.1% | -95.7% | +307.4% |
| Cost of Revenue | $136K | $657K | $318K | $5K | $119K |
| Gross Profit | -$67K | $41K | -$33K | $7K | -$69K |
| Gross Margin | -98.2% | 5.9% | -11.5% | 56.6% | -139.1% |
| R&D Expenses | $0 | $0 | $0 | $26K | $27K |
| SG&A Expenses | $84K | $899K | $2M | $901K | $2M |
| Operating Expenses | $106K | $940K | $2M | $928K | $2M |
| Operating Income | -$173K | -$664K | -$2M | -$921K | -$2M |
| Operating Margin | -252.9% | -95.0% | -575.4% | -7545.5% | -4530.1% |
| Interest Expense | $0 | $471K | $0 | $0 | $0 |
| Income Before Tax | -$173K | -$1M | -$2M | -$1M | -$5M |
| Tax Expense | $0 | $471K | $0 | $0 | $0 |
| Net Income | -$173K | -$2M | -$2M | -$1M | -$5M |
| Net Margin | -252.9% | -230.0% | -581.4% | -8450.2% | -9104.5% |
| EPS (Diluted) | $-0.01 | $-0.04 | $-0.05 | $-0.15 | $-0.21 |
| EBITDA | -$172K | -$898K | -$2M | -$917K | -$2M |
| Shares Outstanding | 27M | 27M | 34M | 7M | 22M |